Article Text

Download PDFPDF
Transient correction of the basic defect in sweat glands in an individual with cystic fibrosis carrying the complex CFTR allele F508del-R553Q
  1. B Tümmler1,2,
  2. F Stanke1,
  3. I Bronsveld3,
  4. H Veeze4,
  5. M Ballmann2
  1. 1
    Klinische Forschergruppe, Medizinische Hochschule Hannover, Hannover, Germany
  2. 2
    Abteilung für Pädiatrische Pneumologie und Neonatologie, Medizinische Hochschule Hannover, Hannover, Germany
  3. 3
    Department of Pulmonology and Tuberculosis, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands
  4. 4
    Stichting Diabeter, Rotterdam, The Netherlands
  1. Dr B Tümmler, Klinische Forschergruppe, OE 6710, Medizinische Hochschule Hannover, Carl-Neuberg-Str 1, D-30625 Hannover, Germany; tuemmler.burkhard{at}mh-hannover.de

Abstract

The molecular pathology of mutant F508del CFTR is partially corrected in vitro by the secondary amino acid substitution R553Q in the ABC signature motif. An individual with the CFTR genotype R553X/F508del-R553Q showed the typical symptoms and electrophysiological anomalies of cystic fibrosis in the airways and intestine. Sweat chloride concentrations were normal early in life, but were later raised into the range that is diagnostic for cystic fibrosis, suggesting that R553Q could temporarily correct the basic defect in sweat glands. R553Q caused a delay in diagnosis because of false negative sweat tests but was not a disease reverting suppressor mutation as had been inferred from cellular models.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Funding: The subject was evaluated within a research project sponsored by the Deutsche Forschungsgemeinschaft (DFG; SFB 621, project C7).

  • Competing interests: None.

  • Ethics approval: Ethics approval was obtained.